References
- Krcmery V, Jr, Mrazova M, Kunova A, et al. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 1999; 7: 428–431
- Puzniak L, Teutsch S, Powderly W, Polish L. Has the epidemiology of nosocomial candidemia changed?. Infect Control Hosp Epidemiol 2004; 25: 628–633
- Redding SW, Marr KA, Kirkpatrick WR, Coco BJ, Patterson TF. Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation. Med Mycol 2004; 42: 479–481
- Carlotti A, Grillot R, Couble A, Villard J. Typing of Candida krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe. J Clin Microbiol 1994; 32: 1691–1699
- Carlotti A, Chaib F, Couble A, et al. Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1. J Clin Microbiol 1997; 35: 1337–1343
- Patterson TF, Revankar SG, Kirkpatrick WR, et al. Simple method for detecting fluconazole-resistant yeasts with chromogenic agar. J Clin Microbiol 1996; 34: 1794–1797
- Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 154–163
- Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309–316